A 24-Week Study of Topical Pirenzepine or Placebo in Type 2 Diabetic Patients (T2DM) With Peripheral Neuropathy

Clinical trial NCT04005287 · COMPLETED

Trial details

NCT number: NCT04005287
Sponsor: WinSanTor, Inc
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Peripheral Neuropathy Painful Diabetic Neuropathy Diabetic Neuropathies, Painful

Start date: 2019-10-15
Primary completion: 2021-12-15
Enrollment: 58

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.